Reliv International Turns 25, Looks to Future Growth

Share Article

Reliv’s emergence as nutritional epigenetics company promises new opportunities for expansion in the years to come.

Reliv, Reliv 25, lunasin, LunaRIch, Reliv nutrition, Reliv business, Reliv opportunity

Reliv 25 marks the celebration of Reliv's 25 years in business in 2013.

As Reliv celebrates its 25th anniversary today, we’re confident that our products have never been more effective and our business opportunity never more limitless.

Reliv International, Inc. (NASDAQ: RELV), a maker of nutritional supplements that promote optimal health, today celebrated the 25th anniversary of first opening its doors on October 8, 1988. The company marked the occasion with a reception for employees at Reliv headquarters. Reliv had previously celebrated its 25th anniversary with Distributors from around the world at the 2013 Reliv International Conference in Orlando on July 18-20.

“Today we look back on our many accomplishments over the past 25 years, but more importantly look forward to the limitless possibilities that lie ahead,” said Ryan Montgomery, Reliv president. “In the past year we’ve positioned ourselves as the industry leader in the emerging field of nutritional epigenetics, and I believe that makes Reliv the ideal entrepreneurial opportunity for potential distributors: an established company on the cutting edge of new technology.”

The Nutritional Epigenetics Company

In July 2013, Reliv entered into an exclusive license for the intellectual property of Soy Labs LLC related to the nutritional ingredient lunasin. Lunasin is a naturally occurring peptide research has identified as the key to many of soy’s documented health benefits, from cholesterol reduction to general cellular health. Learn more about the benefits of lunasin.

Lunasin is the first nutritional compound identified to promote optimal cellular health through an epigenetic mechanism of action. Epigenetics is the study of changes in gene expression in cells caused by mechanisms other than changes in DNA. Lunasin attaches itself to the epigenome in the cell to increase expression of important genes needed for normal cell functioning and protect the cells from environmental damage once it occurs. Learn more about lunasin and epigenetics.

LunaRich from Reliv

LunaRich® from Reliv optimizes bioactive lunasin like no other product available today. LunaRich is made from non-GMO soybean varieties with the highest concentration of lunasin and manufactured using proprietary technologies that maintain the lunasin’s bioactivity.

“LunaRich and the epigenetic science behind it offer a breakthrough new way for people to take control of their health,” said Montgomery. “Today’s health care crisis is creating an explosion in preventive approaches to wellness. So the idea that you can help direct your DNA naturally through nutrition holds the potential for mass appeal. No other products are poised to fill this market need like Reliv’s LunaRich line. As Reliv celebrates its 25th anniversary today, we’re confident that our products have never been more effective and our business opportunity never more limitless.”

About Reliv International, Inc.
Reliv International, based in Chesterfield, Mo., produces nutritional supplements that promote optimal nutrition along with premium skincare products. Reliv supplements address essential nutrition, weight loss,athletic performance, digestive health, women's health, anti-aging and healthy energy. Reliv is the exclusive provider of LunaRich® products, which optimize levels of lunasin, the peptide behind many of soy’s health benefits. The company sells its products through an international network marketing system of independent distributors in 16 countries. Learn more about Reliv at http://www.reliv.com, or on Facebook, Twitter or YouTube.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Mark Murphy
Visit website